Should I Buy schro Dinger Inc (SDGR)? Finance YouTuber Analysis

The YouTuber suggests Schrodinger as a riskier but potentially high-reward AI drug discovery play. While it has negative revenue growth and deeper losses than Recursion, its software licensing revenue helps minimize cash burn. The low price-to-sales valuation compared to peers suggests that much of the bad news may already be priced in, offering significant upside if good news emerges.

“The reason I'm including shrodinger in our list beyond that strong interest in AI drug discovery that could make this a 10 bagger stock still is that much of the bad news could already be priced in with a price to sales valuation of just 7.4 times.”

The YouTuber suggests Schrodinger Inc. as another AI drug discovery play, noting its revenue from licensing software helps minimize cash burn while developing its pipeline. He points to its collaborations with major pharmaceutical companies and a strong cash position to cover operational expenses.

“another key player in this AI drug Discovery theme schro Dinger Inc tier sdgr”